Page 2 - Medical Industry

India unique market, offers huge growth potential: Alma Lasers CEO Dayan

India offers huge growth potential for Alma Lasers, a global leader in energy-based medical and aesthetic solutions, and it plans to expand its product portfolio in the country by introducing additional platforms, injectables, and skincare solutions, according to a top company official. Alma is a leading Israeli company specialising in the innovation and manufacturing of medical lasers, light-based, radiofrequency, and ultrasound platforms for the aesthetics, surgical, and beauty (spa) markets. It has a strong presence across Asia, particularly in India, China, Korea, Japan, and Australia. Alma operates directly in these regions through its subsidiaries. Speaking during the opening ceremony of Alma Academy in Thailand held between September 26-29, that saw attendance from 340 physicians and company partners from 34 countries, Alma Lasers CEO Lior Dayan said, over the past 25 years, the company has partnered with numerous clinics to advance the field of aesthetic treatments, deliveri

Medical gear makers up in arms against zero-duty imports under EU FTA

India is 70% import-dependent, and Germany and the Netherlands are among the top five countries

Uttar Pradesh generated majority tokens under NHA's digital OPD scheme

Scheme a mixed bag as TN, Kerala record less than 10,000 digital OPD tokens till now

Govt plans to launch central database for allied healthcare professionals

Move comes amid SC's directive to Centre, states to implement NCAHP Act by October 2024

Senior care market grows in 'out of hospital' services in Tier-II cities

According to a recent NITI Aayog report on state of senior care in India released in February 2024, size of senior care industry in India is about $7 billion, having grown rapidly in last five years

Medical bodies condemn mob attack on protesting doctors in Kolkata

Strike continues for fourth day; doctor bodies call for protest march in Delhi

Narayana Hrudalaya's consolidated revenue rises 8.7% to Rs 1,364.4 cr in Q1

The hospital chain reported a net profit of Rs 201.49 crore in Q1FY25 as compared to Rs 184.04 crore in Q1FY24

Centre, states must collaborate for global investment in India: Mukesh Aghi

Mukesh Aghi talks about the recent Lok Sabha elections, expectations from the coming Budget, changes in India's regulatory environment.

MedPlus Health Q4 results: Consolidated net profit up 25.6% at Rs 33.39 cr

MedPlus competes with Reliance-owned Netmeds and Apollo Pharmacies among other retail pharmacies in the Indian OTC drugs market

Number of medical tourists in India to exceed pre-pandemic levels in CY24

Major hospital chains in India are eyeing the rise in international patient revenue and exploring entry into new geographies

India's role in medical product space represents unique opportunity: FDA

The role of India in the medical product field represents both a unique opportunity and an important responsibility, the head of the US Food and Drug Administration has said, ahead of the annual India-US BioPharma & Healthcare Summit. The summit will take place in Boston later this week. Dr Robert Califf, US FDA Commissioner will be one of the keynote speakers at the 18th edition of the annual largest gathering of pharma and healthcare sectors from the two countries, organised by USA India Chamber of Commerce. During the day-long summit, Dr Califf will share insights from his significant visit to India last September, which holds paramount importance for both countries, USA India Chamber of Commerce said in a statement on Sunday. I recently visited India with a central purpose in mindto strengthen our collective efforts to advance the development and availability of medical products that both our countries and the rest of the world need, he said. I knew, going into my trip, that .

MaxPetZ to use 3D printing for reconstructive surgeries in veterinary field

Speaking on the subject, Leena Dalal, senior veterinary surgeon and oncologist MaxPetZ said that this would be the first time in India that 3D Printing is being used to treat animals

Vital signs of change: AI now lifeblood of India's hospital chains

All the major healthcare chains like Apollo Hospitals, Manipal Healthcare, and Aster DM Healthcare, among others, are using AI in prediction, prevention, diagnosis, and personalized management

SS Innovations to start first human trials for remote telesurgery soon

Srivastava added that telesurgery will allow surgeons to perform procedures on patients who are not physically present in the same location as them

Rise in number of C-sections across India between 2016 and 2021: Study

A caesarean section (C-section) delivery is a surgical technique that involves making an incision in the mother's belly to deliver one or more infants

Maxivision Super Specialty Eye Hospitals eyes 100 facilities: Chairman

Maxivision Super Specialty Eye Hospitals has set up its fifth facility in Tamil Nadu, the 46th such facility in the country, set up under its expansion plan a top official said on Tuesday. The eye care provider has targeted setting up 100 hospitals by 2025, Promoter and Chairman GSK Velu said. Maxivision had signed a memorandum of understanding with the Government of Tamil Nadu to set up eye care facilities in Perambalur, Thanjavur, Tiruchirappalli and Salem, under its 'Project Velicham' initiative. The new facility in Madurai, spread across 8,000 sq ft was inaugurated by Tamil Nadu Minister for Commercial Taxes and Registration P Moorthy in the presence of Maxivision Group CEO VS Sudheer, Regional Medical Director Shibu Varkey. "It is with great pride that we have opened our state-of-the-art hospital in the temple city. Currently, we have five centres in Tamil Nadu. With the inauguration of this centre, Maxivision Super Specialty Eye Hospitals now has a total network presence of 4

Doctors in South Korea submit resignations, widening medical school dispute

Senior doctors at major hospitals in South Korea began submitting their resignations en masse Monday in support of medical interns and residents who have been on a strike for five weeks over the government's push to sharply increase medical school admissions. The senior doctors' action won't likely cause an immediate worsening of hospital operations in South Korea because they have said they would continue to work even after submitting their resignations. But prospects for an early end to the medical impasse were also dim, as the doctors' planned action comes after President Yoon Suk Yeol called for talks with doctors while suggesting a possible softening of punitive steps against the striking junior doctors. About 12,000 interns and medical residents have faced impending suspensions of their licenses over their refusal to end their strikes, which have caused hundreds of cancelled surgeries and other treatments at their hospitals. They oppose the government's plan to increase the ..

MeraDoc partners with MakeMyTrip to offer real-time medical services

HealthTech startup and India's fastest-growing online medical services company Meradoc has entered into a strategic partnership with travel booking MakeMyTrip to offer a bouquet of healthcare services on the go for the latter's subscribers across the country. With this alliance, Meradoc's digital-health platform and its services will now become available 24x7 on a real-time basis to MakeMyTrip customers across India, the company said in a statement. "The ground-breaking partnership will provide MakeMyTrip customers round-the-clock instant access to Meradoc's panel of qualified doctors through video and audio consultations," it said. Additionally, pathology services, personalised follow-ups and updates, as also delivery of medicines prescribed by the doctors, will be available to MakeMyTrip customers at their doorstep within two hours, whether they are at home or travelling anywhere in the country on business or for personal reasons. Set up in 2021 by Sudhir Mathur, ex-CEO of Cairn

India failed to meet WHO End-TB target, cases fall 0.5% in 2015-20: Lancet

India's tuberculosis incidence dropped marginally by 0.5 per cent between 2015 and 2020 and failed to meet the World Health Organization's (WHO's) END-TB milestone for 2020, according to new global research published in The Lancet Infectious Diseases journal. The WHO End TB Strategy aims for a 90 per cent reduction in TB deaths and an 80 per cent reduction in the incidence rate by 2030, compared to the baseline figures of 2015. The 2020 milestones include a 20 per cent reduction in the TB incidence rate and a 35 per cent reduction in deaths. The latest study estimated that the incidence of TB across all ages in India was 213 cases per one lakh population in 2020, well above the WHO's milestone figure (for India) of 171 per one lakh population. Deaths due to the bacterial infectious disease in the same year were estimated to be between 3.5-5 lakh, again much above the mortality milestone of 2.7-3.2 lakh set for India. The study comes ahead of World Tuberculosis Day on March 24. Desp

Engrail Therapeutics closes oversubscribed $157 million Series B financing

Funding from the Series B round will propel the advancement of the company's pipeline through multiple stages of clinical development